| Ocean State Primary Care Center Of East Providence Inc | |
|
450 Veterans Memorial Pkwy Unit 15b East Providence RI 02914-5300 | |
| (401) 434-3350 | |
| Not Available |
| Full Name | Ocean State Primary Care Center Of East Providence Inc |
|---|---|
| Speciality | Family Medicine |
| Location | 450 Veterans Memorial Pkwy Unit 15b, East Providence, Rhode Island |
| Authorized Official Name and Position | Jennifer Zuba (GENERAL MANAGER) |
| Authorized Official Contact | 4016262748 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ocean State Primary Care Center Of East Providence Inc 2130 Mendon Rd Ste 3-333 Cumberland RI 02864-3844 Ph: (401) 353-1012 | Ocean State Primary Care Center Of East Providence Inc 450 Veterans Memorial Pkwy Unit 15b East Providence RI 02914-5300 Ph: (401) 434-3350 |
| NPI Number | 1225543754 |
|---|---|
| Provider Enumeration Date | 12/06/2017 |
| Last Update Date | 12/06/2017 |
| Medicare PECOS PAC ID | 4082974233 |
|---|---|
| Medicare Enrollment ID | O20180207001837 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225543754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 363LA2200X | Nurse Practitioner - Adult Health | (* (Not Available)) | Secondary |
| Provider Name | Paul Santoro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932194198 PECOS PAC ID: 9032018536 Enrollment ID: I20040105000186 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Frank Michael D'alessandro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225018955 PECOS PAC ID: 1759275050 Enrollment ID: I20040720000671 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Daniel T Shreve |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134239767 PECOS PAC ID: 4284690538 Enrollment ID: I20041208000317 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Okosun E Edoro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1063611481 PECOS PAC ID: 3577538099 Enrollment ID: I20081216000294 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Richard M Bianco |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649355991 PECOS PAC ID: 6406031855 Enrollment ID: I20110428000170 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Phyllis Kelliher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598101925 PECOS PAC ID: 8527200518 Enrollment ID: I20130802000817 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Gerda Newcomb |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417331521 PECOS PAC ID: 6901167725 Enrollment ID: I20180219000853 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Anthony Kyle Sampino |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1982081832 PECOS PAC ID: 7315247533 Enrollment ID: I20190619003268 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
| Provider Name | Faithe Weathers |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750850665 PECOS PAC ID: 4486991528 Enrollment ID: I20190710001052 |
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
News Archive
Titan Pharmaceuticals, Inc today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan's United States patent application directed to the use of Probuphine for the treatment of opiate addiction.
A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed in his Ph.D. thesis optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease.
Researchers in Britain say advertising aimed at encouraging the safe drinking of alcohol are unsuccessful - they are calling for the "demonising" of young people in order to promote safe drinking to be stopped.
A coalition of 100 U.K. development charities and faith groups on Wednesday launched the IF campaign, aimed at addressing global hunger. The following is a summary of opinion pieces published in response to the campaign's launch.
The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.
› Verified 2 days ago
Alex Mandel, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Massasoit Ave, Suite 300, East Providence, RI 02914 Phone: 401-434-8226 Fax: 401-434-4178 | |
East Providence Senior Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 610 Waterman Ave, East Providence, RI 02914 Phone: 401-435-7800 Fax: 401-435-7803 | |
Broadway Medical Treatment Center, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1053 S Broadway, East Providence, RI 02914 Phone: 401-438-5551 Fax: 401-438-7272 | |
Dr Michael C Souza, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2761 Pawtucket Ave, East Providence, RI 02914 Phone: 401-434-3350 Fax: 401-434-5230 | |
Daniela Turacova Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 525 Taunton Avenue, Suite 100, East Providence, RI 02914 Phone: 401-438-0888 | |
Dsmt At East Providence Senior Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 610 Waterman Ave, East Providence, RI 02914 Phone: 401-435-7800 Fax: 401-435-7803 | |
Primary Medical Center And Walk-in Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 684 Warren Ave, East Providence, RI 02914 Phone: 401-434-0022 Fax: 401-434-6111 |